These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37080348)

  • 1. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
    Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study.
    Miyakawa J; Yamada Y; Hakozaki Y; Makino K; Kamei J; Taguchi S; Kawai T; Akiyama Y; Yamada D; Kume H
    Photodiagnosis Photodyn Ther; 2024 Aug; 48():104254. PubMed ID: 38901718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
    Nakagawa R; Nohara T; Kano H; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Mizokami A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104023. PubMed ID: 38401816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    PLoS One; 2018; 13(11):e0208267. PubMed ID: 30496283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
    Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
    Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
    Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H
    Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
    Fukuhara H; Hagiwara Y; Oba K; Inoue K
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Photodynamic Diagnosis Cystoscopy After Bacillus Calmette-Guérin (BCG) Induction for High-Risk Nonmuscle Invasive Bladder Cancer Significantly Increased the Detection of BCG Refractory Tumors.
    Morelli M; Baboudjian M; Vanacore D; Gondran-Tellier B; McManus R; Karsenty G; Lechevallier E; Montanari E; Boissier R
    J Endourol; 2021 Dec; 35(12):1824-1828. PubMed ID: 34107773
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response.
    Hensley PJ; Bree KK; Brooks N; Matulay J; Li R; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2021 Nov; 128(5):634-641. PubMed ID: 33783950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.
    Nishiyama N; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Kitamura H; Masumori N
    Urol Oncol; 2018 Jun; 36(6):306.e9-306.e15. PubMed ID: 29550096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid.
    Makino T; Ofude M; Kawahara T; Hori T; Urata S; Miyagi T
    In Vivo; 2022; 36(6):2952-2959. PubMed ID: 36309406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
    Fujita N; Hatakeyama S; Okita K; Momota M; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2021 Mar; 39(3):191.e9-191.e16. PubMed ID: 32713622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
    Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.
    Sfakianos JP; Kim PH; Hakimi AA; Herr HW
    J Urol; 2014 Feb; 191(2):341-5. PubMed ID: 23973518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.